Metastatic Melanoma Therapy, Imlygic, Now Available in EU
News
Amgen announced that the European Commission (EC) has approved Imlygic as a treatment for adult patients with unresectable melanoma that is regionally or distantly metastatic — Stage IIIB, IIIC and IVM1a ... Read more